Should doctors inform patients if they have untreatable genetic diseases?

Screen Shot at PM

Ethical considerations related to consent, privacy, and confidentiality have been upended by genetic testing, according to members of a panel…at the European Society for Immunodeficiencies 2016 Biennial Meeting.

In the future, gene sequencing will likely be used to screen newborns for primary deficiencies, [Alain Fischer] pointed out….

Patients must wrestle with how much they want to be told and whether they can trust that the information will be confidential. And…if there is no treatment for a disease, do patients, or their parents, want to know they have it?

“We need to do research in sociology to better understand how people perceive the information we give to them,” [Dr. Fischer] added. “It’s no longer a question.”

“I don’t think it’s a privilege of patients to say they have a right to remain ignorant,” Dr. [Simon] Woods explained. “I know some people choose not to know their genetic heritage, but it seems…reasonable to challenge that in a gentle and fair way because patients, too, have moral responsibilities,” he said.

Free account signup required to access article.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Genetic Test Results Spur Ethical Dilemmas

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.